Thyroid disease

Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study

Eur Thyroid JPublished Population-based cohort study

Authors' conclusion

This is the first study establishing a TPP cohort based on validated clinical data from an electronic medical database. It is important to keep monitoring the increasing incidence rate of thyrotoxicosis.

Study context

Population
Thyrotoxicosis and thyrotoxic periodic paralysis (TPP) cases identified from a representative electronic medical database in Hong Kong, 2002–2021
Participants
77,856 vs 994
Exposure
Thyrotoxicosis vs TPP
  • Thyrotoxicosisn = 77,856
  • TPPn = 994
Outcome
Standardized incidence rate of thyrotoxicosis and TPP and its trend
Follow-up
2002 to 2021
Methodological detailselectronic medical database, validated case-identification algorithms
  • Electronic medical database
  • Validated case-identification algorithms

Main finding

As reported in the abstract

Age- and sex-standardized incidence rate of thyrotoxicosis (per 100,000 person-years)
Thyrotoxicosis incidence in 2002
41.31
Thyrotoxicosis incidence in 2021
69.51
Average annual percentage change
4.77%
TPP age-standardized incidence in males, 2002 and 2021
1.43 and 1.18
TPP age-standardized incidence in females, 2002 and 2021
0.11 and 0.13

Observational data: associations, not effects.

Further findings

Algorithm validation: PPV for thyrotoxicosis and TPP

PPV
0.86-0.97
  • 200 randomly selected cases reviewed

TPP patient characteristics

Male
93.66%

TPP-associated hospitalization rate and median length of stay (LOS) · 2002 to 2021

TPP-associated hospitalization rate, steady
90.91-100%
Median LOS, steady
2-3 days

Original publication

Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study. Eur Thyroid J. Published 5 September 2025. doi:10.1530/etj-25-0220

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.